[go: up one dir, main page]

AU2019902698A0 - Methods and compositions - Google Patents

Methods and compositions

Info

Publication number
AU2019902698A0
AU2019902698A0 AU2019902698A AU2019902698A AU2019902698A0 AU 2019902698 A0 AU2019902698 A0 AU 2019902698A0 AU 2019902698 A AU2019902698 A AU 2019902698A AU 2019902698 A AU2019902698 A AU 2019902698A AU 2019902698 A0 AU2019902698 A0 AU 2019902698A0
Authority
AU
Australia
Prior art keywords
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019902698A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2019902698A0 publication Critical patent/AU2019902698A0/en
Priority to PCT/AU2020/050145 priority Critical patent/WO2021016652A1/en
Abandoned legal-status Critical Current

Links

AU2019902698A 2019-07-29 2019-07-29 Methods and compositions Abandoned AU2019902698A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2020/050145 WO2021016652A1 (en) 2019-07-29 2020-02-20 METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS

Publications (1)

Publication Number Publication Date
AU2019902698A0 true AU2019902698A0 (en) 2019-08-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3843729A4 (en) Novel compositions and methods
EP3917497A4 (en) Oligonucleotide compositions and methods thereof
EP4051017A4 (en) Probiotic compositions and methods
EP4003936A4 (en) Whitening methods and compositions
SG11202108262VA (en) Bacterialcidal methods and compositions
EP3919612A4 (en) Composition and application thereof
HK40076659A (en) Biopharmacuetical compositions and related methods
AU2019904455A0 (en) Compositions and methods
AU2019902698A0 (en) Methods and compositions
AU2019901465A0 (en) Compositions and methods
HK40074178A (en) Composition and methods
HK40056263A (en) Compositions and methods
HK40060519A (en) Methods and compositions
HK40052685A (en) Anti-cd112r compositions and methods
HK40057187A (en) Novel compositions and methods
AU2019904920A0 (en) Compositions and uses thereof
AU2019904921A0 (en) Compositions and uses thereof
AU2019904813A0 (en) Compositions and uses thereof
AU2019903417A0 (en) Compositions and uses thereof
AU2018902622A0 (en) Methods and compositions
AU2018902624A0 (en) Methods and compositions
AU2018902623A0 (en) Methods and compositions
AU2018902207A0 (en) Compositions and methods
AU2018901266A0 (en) Compositions and methods
HK40070562A (en) Immunomodulatory compositions and methods